Astria Therapeutics, Inc. (ATXS)
12.96
-0.04
(-0.35%)
USD |
NASDAQ |
Dec 09, 16:00
12.96
0.00 (0.00%)
After-Hours: 18:20
Astria Therapeutics Profit Margin (Quarterly): -4.48K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 8.09% |
| Hologic, Inc. | 17.85% |
| Johnson & Johnson | 21.47% |
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| CorMedix, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -42.95% |
| Return on Assets | -39.55% |
| Return on Invested Capital | -42.21% |
| Operating Margin (Quarterly) | -4.83K% |
| Return on Net Operating Assets | -1.50K% |